Oragenics, Inc. (OGEN)

Oragenics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.02	0.04	0.13	0.09	0	0
Revenue Growth (YoY)	-84.54%	-71.37%	51.20%	-	-	-
Gross Profit	0.02	0.04	0.13	0.09	0	0
Selling, General & Admin	6	5.45	4.48	5.27	4.53	3.76
Research & Development	14.48	15.49	10.07	10.59	22.11	12.12
Operating Expenses	20.48	20.94	14.55	15.86	26.64	15.88
Operating Income	-20.46	-20.9	-14.42	-15.77	-26.64	-15.88
Interest Expense / Income	0.03	0.03	0.02	0.02	0.01	0.01
Other Expense / Income	-0.23	-0.28	-0.15	-0.08	-0.22	-0.32
Pretax Income	-20.26	-20.66	-14.29	-15.71	-26.43	-15.57
Net Income	-20.26	-20.66	-14.29	-15.71	-26.43	-15.57
Shares Outstanding (Basic)	3	2	2	2	1	1
Shares Outstanding (Diluted)	3	2	2	2	1	1
Shares Change	58.57%	11.97%	3.40%	106.24%	33.69%	224.29%
EPS (Basic)	-8.54	-9.18	-7.11	-8.09	-28.20	-22.20
EPS (Diluted)	-8.54	-9.18	-7.11	-8.09	-28.20	-22.20
Free Cash Flow	-8.18	-7.23	-15.34	-13.51	-16.95	-13.04
Free Cash Flow Per Share	-2.34	-3.21	-7.64	-6.96	-17.99	-18.50
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-99181.69%	-55519.89%	-10964.61%	-18130.32%	-	-
Profit Margin	-98219.66%	-54858.14%	-10863.96%	-18062.03%	-	-
Free Cash Flow Margin	-39666.09%	-19194.13%	-11666.58%	-15535.76%	-	-
EBITDA	-20.21	-20.6	-14.23	-15.65	-26.37	-15.5
EBITDA Margin	-97975.26%	-54704.15%	-10818.51%	-17996.51%	-	-
Depreciation & Amortization	0.02	0.03	0.04	0.04	0.05	0.06
EBIT	-20.23	-20.63	-14.27	-15.7	-26.42	-15.56
EBIT Margin	-98053.25%	-54776.90%	-10852.48%	-18043.91%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).